摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cbz-L-缬氨醇 | 6216-65-5

中文名称
Cbz-L-缬氨醇
中文别名
CBZ-L-缬氨醇
英文名称
N-benzyloxycarbonyl-L-valinol
英文别名
(S)-benzyl (1-hydroxy-3-methylbutan-2-yl)carbamate;Cbz-L-valinol;benzyl N-[(2S)-1-hydroxy-3-methylbutan-2-yl]carbamate
Cbz-L-缬氨醇化学式
CAS
6216-65-5
化学式
C13H19NO3
mdl
——
分子量
237.299
InChiKey
BGHASJBQTDDGLA-GFCCVEGCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    17
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    58.6
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2924299090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:ed5a66b1fa7fe2679fc70a5af3d8da47
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    Cbz-L-缬氨醇 在 palladium on activated charcoal 氢气 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 3.0h, 生成 L-缬氨醇
    参考文献:
    名称:
    Synthesis of Peptide Aldehyde Derivatives as Selective Inhibitors of Human Cathepsin L and Their Inhibitory Effect on Bone Resorption
    摘要:
    Cathepsin L, a lysosomal cysteine protease, is secreted by osteoclasts and participates in bone collagen degradation. In a search for cathepsin L inhibitors as antiosteoporotic agents, a series of peptide aldehyde derivatives were prepared by two synthetic approaches, DMSO oxidation of the corresponding alcohol derivatives and DIBAL-H reduction of the corresponding N,O-dimethylhydroxylamide derivatives, and evaluated for inhibitory activity against human cathepsin L and for inhibitory effects on bone resorption. Some of the peptide aldehyde derivatives including alpha-acylamino aldehyde derivatives showed potent activities. Among these compounds, N-(1-naphthalenylsulfonyl-L-isoleucyl-L-tryptophanal (12) was selected as a candidate for further investigation. Compound 12, a potent, selective, and reversible inhibitor of human cathepsin L with an IC50 Of 1.9 nM, inhibited the release of Ca2+ and hydroxyproline from bone in in vitro bone culture system and also prevented bone loss in ovariectomized mice at an oral dose of 50 mg/kg.
    DOI:
    10.1021/jm9803065
  • 作为产物:
    描述:
    (S)-(S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanoic (ethyl carbonic) anhydride 在 sodium tetrahydroborate 作用下, 生成 Cbz-L-缬氨醇
    参考文献:
    名称:
    Madhu, Chilakapati; Panguluri, Nageswara Rao; Sureshbabu, Vommina V., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53, # 7, p. 858 - 864
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Heterocyclic ketones
    申请人:ICI Americas Inc.
    公开号:US05164371A1
    公开(公告)日:1992-11-17
    The invention provides a series of novel heterocyclic ketones of formula I ##STR1## and pharmaceutically acceptable base-addition salts thereof, in which the values of R.sup.4, L, A, X and Q have the meanings defined in the following specification. The compounds of formula I are inhibitors of human leukocytic elastase. The invention also provides pharmaceutical compositions containing a compound of formula I, or a pharmaceutically acceptable base-addition salt thereof, and processes and intermediates for the manufacture of compounds of formula I.
    这项发明提供了一系列新颖的杂环酮化合物,其化学式为I ##STR1## 及其药用可接受的盐,其中R.sup.4、L、A、X和Q的值如下文规定。化合物I的是人类白细胞弹性蛋白酶的抑制剂。该发明还提供了含有化合物I或其药用可接受的盐的药物组合物,以及化合物I的制备过程和中间体。
  • Optically Active N- and C-Terminal Building Blocks for the Synthesis of Peptidyl Olefin Peptidomimetics
    作者:Sima Mirilashvili、Naama Chasid-Rubinstein、Amnon Albeck
    DOI:10.1002/ejoc.201000539
    日期:2010.8
    peptidomimetics serve as biologically active compounds or as intermediates for other peptidyl isosteres. The N-terminal side of the C=C bond could be easily prepared in an optically pure form from α-amino acids. Synthesis of C-terminal building blocks in an optically pure form is more challenging. We developed a chemoenzymatic stereoselective approach to such optically active C-terminal building blocks to
    肽基烯烃肽模拟物用作生物活性化合物或用作其他肽基等排体的中间体。C=C 键的 N 端侧可以很容易地从 α-氨基酸以光学纯的形式制备。以光学纯形式合成 C 端结构单元更具挑战性。我们开发了一种化学酶立体选择性方法,用于通过各种反应组装成肽基烯烃的光学活性 C 端结构单元。它们包括亲电子醛和亲核砜、鏻盐、膦酸盐和二硒化物。前手性二酯到相应羟基酯的关键酶水解引入了光学活性。随后化学反应的顺序,无论是保护-水解-功能化还是功能化-水解-保护,
  • Discovery of Peptidomimetic Antibody–Drug Conjugate Linkers with Enhanced Protease Specificity
    作者:BinQing Wei、Janet Gunzner-Toste、Hui Yao、Tao Wang、Jing Wang、Zijin Xu、Jinhua Chen、John Wai、Jim Nonomiya、Siao Ping Tsai、Josefa Chuh、Katherine R. Kozak、Yichin Liu、Shang-Fan Yu、Jeff Lau、Guangmin Li、Gail D. Phillips、Doug Leipold、Amrita Kamath、Dian Su、Keyang Xu、Charles Eigenbrot、Stefan Steinbacher、Rachana Ohri、Helga Raab、Leanna R. Staben、Guiling Zhao、John A. Flygare、Thomas H. Pillow、Vishal Verma、Luke A. Masterson、Philip W. Howard、Brian Safina
    DOI:10.1021/acs.jmedchem.7b01430
    日期:2018.2.8
    Antibody–drug conjugates (ADCs) have become an important therapeutic modality for oncology, with three approved by the FDA and over 60 others in clinical trials. Despite the progress, improvements in ADC therapeutic index are desired. Peptide-based ADC linkers that are cleaved by lysosomal proteases have shown sufficient stability in serum and effective payload-release in targeted cells. If the linker
    抗体-药物偶联物(ADC)已成为肿瘤学的重要治疗手段,其中三种已获得FDA批准,另外60多项已在临床试验中获得批准。尽管取得了进步,但仍需要改善ADC治疗指数。被溶酶体蛋白酶裂解的基于肽的ADC接头在血清中显示出足够的稳定性,并在靶细胞中有效释放有效负载。如果该接头可以被肿瘤特异性蛋白酶优先水解,则安全系数可能会提高。但是,基于肽的接头的使用限制了我们调节蛋白酶特异性的能力。在这里,我们报告新型非肽类ADC接头的结构指导发现。我们表明,含有环丁烷-1,1-二羧酸的连接子主要被组织蛋白酶B水解,而缬氨酸-瓜氨酸二肽连接子则不被水解。带有非肽接头的ADC在体内与具有二肽接头的ADC一样有效和稳定。我们的结果有力地支持了拟肽连接子的应用,并为改善ADC的选择性提供了新的机会。
  • O-Alkyl S-(Pyridin-2-yl)carbonothiolates: Operationally Simple and Highly Nitrogen-Selective Reagents for Alkoxy Carbonylation of Amino Groups
    作者:Osamu Tamura、Tomoyuki Suzuki、Kosaku Tanaka、Yoshimitsu Hashimoto、Nobuyoshi Morita
    DOI:10.1055/s-0039-1690856
    日期:2020.6
    Amino groups are selectively protected in good yields by reaction with O-alkyl S-(pyridin-2-yl)carbonothiolates in an appropriate solvent at room temperature in air. Even glucosamine, which contains multiple hydroxyl groups, is selectively N-protected in methanol.
    通过与 O-烷基 S-(吡啶-2-基)碳硫醇盐在适当的溶剂中在室温下在空气中反应,氨基以良好的产率被选择性地保护。甚至含有多个羟基的葡糖胺也在甲醇中被选择性地 N 保护。
  • Synthesis of β-aminoethanesulfonyl fluorides or 2-substituted taurine sulfonyl fluorides as potential protease inhibitors
    作者:Arwin J. Brouwer、Tarik Ceylan、Tima van der Linden、Rob M.J. Liskamp
    DOI:10.1016/j.tetlet.2009.02.130
    日期:2009.7
    Substituted taurine sulfonyl fluorides derived from taurine or protected amino acids are conveniently synthesized from β-aminoethanesulfonyl chlorides using KF/18-crown-6 or from β-aminoethanesulfonates using DAST.
    衍生自牛磺酸或受保护氨基酸的取代牛磺酸磺酰氟可方便地使用KF / 18-crown-6从β-氨基乙烷磺酰氯合成,或使用DAST从β-氨基乙烷磺酸酯合成。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐